H.Res. 1079 · 119th Congress (2025–2027)
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.Res. 1079’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Josh Gottheimer (D-NJ-5)
- Cosponsors
1 cosponsor
1 original · 0 later
- Rep. Don Bacon (R-NE-2)· Original · Feb 25, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Submitted in House
Document: Introduced in House
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (1)
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Official title, Display title · Introduced in House